Lipid Lowering Treatment: Current Issues
نویسنده
چکیده
Lipid lowering treatment is of benefit in the prevention of coronary heart diseases (CHD) and other vascular events. So far many studies have been carried out to prove the safety, efficacy and beneficial effects of lipid-lowering treatment in various countries. These studies can be categorized into two groups: (1) studies done to prove the effectiveness of lipid lowering treatment in the primary prevention of coronary heart diseases e.g. WOSCOPS or West of Scotland Coronary Prevention Study (1995) and AFCAPS/ TEXCAPS or Airforce/Texas Coronary Atherosclerosis Prevention Study (1995) : (2) studies done to prove the effectiveness of these drugs in the secondary prevention of coronary heart disease e.g. CARE or Cholesterol And Recurrent Events trial (1996) and LIPID or the Long-term Intervention With Pravastatin in Ischaemic Heart Disease (1998).
منابع مشابه
Lipid Lowering Activity of Lercanidipine in Hyperlipidemic Rats
The present study was aimed at evaluating the lipid lowering activity of lercanidipine, a calcium channel blocker, in standard diet induced hyperlipidemic rats. Hyperlipidemic rats were divided into different groups and were treated with daily oral dose of lercanidipine and atorvastatin for 7 days. On 8 th day, blood samples were collected and analyzed for serum lipid levels using commercial k...
متن کاملDespite Affordability, Low Utilization of Lipid Lowering Drugs in Iran: Trend Analysis and Benchmarking 2005-2016
Dyslipidemia is responsible for great mortality and morbidity each year. Little data are available on the availability and affordability of Dyslipidemia medications in low and middle incomes countries. In a retrospective time-series study, we examined the utilization pattern and affordability of lipid-lowering medications in Iran as a lower middle-income country. We initially calculated the def...
متن کاملDespite Affordability, Low Utilization of Lipid Lowering Drugs in Iran: Trend Analysis and Benchmarking 2005-2016
Dyslipidemia is responsible for great mortality and morbidity each year. Little data are available on the availability and affordability of Dyslipidemia medications in low and middle incomes countries. In a retrospective time-series study, we examined the utilization pattern and affordability of lipid-lowering medications in Iran as a lower middle-income country. We initially calculated the def...
متن کاملGlucose and Low-Density Lipoprotein Cholesterol Lowering in Elderly Patients with Type 2 Diabetes
The prevalence of type 2 diabetes mellitus is high among the elderly population. Treatment of elderly patients with type 2 diabetes presents challenges because of co-morbidities and the potential increase in the risk of adverse effects. Hyperlipidaemia is also common in the elderly population. Glucose- and lipid-lowering treatment in elderly patients should be individualized on the basis of the...
متن کاملBeyond statins: what to expect from add-on lipid regulating therapy?
Results of recent lipid lowering trials (Table 1) where new (dalcetrapib) and established agents (niacin) were tested on a background of statin therapy have been disappointingly negative. This outcome has been the cause of much consternation for those developing new lipid regulating drugs, and prompted reflection among experts on long-cherished concepts and the practical implications of continu...
متن کامل